JP7610810B2 - 神経変性疾患のリスク判定方法及び判定装置 - Google Patents

神経変性疾患のリスク判定方法及び判定装置 Download PDF

Info

Publication number
JP7610810B2
JP7610810B2 JP2023556884A JP2023556884A JP7610810B2 JP 7610810 B2 JP7610810 B2 JP 7610810B2 JP 2023556884 A JP2023556884 A JP 2023556884A JP 2023556884 A JP2023556884 A JP 2023556884A JP 7610810 B2 JP7610810 B2 JP 7610810B2
Authority
JP
Japan
Prior art keywords
streptococcus
prevotella
diseases
bacteria
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023556884A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2024062931A1 (https=
Inventor
智宏 赤澤
正平 服部
大介 久松
信孝 服部
亙 須田
勇亮 緒方
隆 朝田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Juntendo University
RIKEN
Original Assignee
Juntendo University
RIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juntendo University, RIKEN filed Critical Juntendo University
Publication of JPWO2024062931A1 publication Critical patent/JPWO2024062931A1/ja
Application granted granted Critical
Publication of JP7610810B2 publication Critical patent/JP7610810B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2023556884A 2022-09-20 2023-09-07 神経変性疾患のリスク判定方法及び判定装置 Active JP7610810B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022149488 2022-09-20
JP2022149488 2022-09-20
PCT/JP2023/032629 WO2024062931A1 (ja) 2022-09-20 2023-09-07 神経変性疾患のリスク判定方法及び判定装置

Publications (2)

Publication Number Publication Date
JPWO2024062931A1 JPWO2024062931A1 (https=) 2024-03-28
JP7610810B2 true JP7610810B2 (ja) 2025-01-09

Family

ID=90454260

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023556884A Active JP7610810B2 (ja) 2022-09-20 2023-09-07 神経変性疾患のリスク判定方法及び判定装置

Country Status (5)

Country Link
US (1) US20260018300A1 (https=)
EP (1) EP4593037A1 (https=)
JP (1) JP7610810B2 (https=)
KR (1) KR20250073634A (https=)
WO (1) WO2024062931A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025197838A1 (ja) * 2024-03-18 2025-09-25 学校法人順天堂 神経変性疾患及び前駆障害の判定方法及び判定装置
CN120600317A (zh) * 2025-06-16 2025-09-05 北京大学口腔医学院 一种识别受试者健康状态的装置及存储介质

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021020198A1 (ja) 2019-07-26 2021-02-04 富士フイルム株式会社 情報処理装置、プログラム、学習済みモデル、診断支援装置、学習装置及び予測モデルの生成方法
JP2021516054A (ja) 2018-03-05 2021-07-01 エムディー ヘルスケア インコーポレイテッドＭｄ Ｈｅａｌｔｈｃａｒｅ Ｉｎｃ． ラクトバチルス属細菌由来のナノ小胞及びその用途
JP2022516988A (ja) 2019-01-09 2022-03-03 エムディー ヘルスケア インコーポレイテッド デイノコッカス属細菌由来ナノ小胞及びその用途

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021516054A (ja) 2018-03-05 2021-07-01 エムディー ヘルスケア インコーポレイテッドＭｄ Ｈｅａｌｔｈｃａｒｅ Ｉｎｃ． ラクトバチルス属細菌由来のナノ小胞及びその用途
JP2022516988A (ja) 2019-01-09 2022-03-03 エムディー ヘルスケア インコーポレイテッド デイノコッカス属細菌由来ナノ小胞及びその用途
WO2021020198A1 (ja) 2019-07-26 2021-02-04 富士フイルム株式会社 情報処理装置、プログラム、学習済みモデル、診断支援装置、学習装置及び予測モデルの生成方法

Also Published As

Publication number Publication date
US20260018300A1 (en) 2026-01-15
WO2024062931A1 (ja) 2024-03-28
KR20250073634A (ko) 2025-05-27
JPWO2024062931A1 (https=) 2024-03-28
EP4593037A1 (en) 2025-07-30

Similar Documents

Publication Publication Date Title
Buckley et al. Cell-type-specific aging clocks to quantify aging and rejuvenation in neurogenic regions of the brain
JP7610810B2 (ja) 神経変性疾患のリスク判定方法及び判定装置
CN105209918B (zh) 生物标记鉴定方法和系统
CN105368944B (zh) 可检测疾病的生物标志物及其用途
Asselstine et al. Genetic mechanisms regulating the host response during mastitis
US20210142906A1 (en) Methods and systems for oral microbiome analysis
AU2013388864A1 (en) Method and system for assessing health condition
CN112852916A (zh) 肠道微生态的标志物组合、辅助诊断模型及其应用
Krivonosov et al. A new cognitive clock matching phenotypic and epigenetic ages
JP7849349B2 (ja) Ｍｃｉ診断マーカー、ｍｃｉ診断キット及びその検出方法
Buckley et al. Cell type-specific aging clocks to quantify aging and rejuvenation in regenerative regions of the brain
CN111370116A (zh) 双相情感障碍疗效预测的肠道微生物标志物及其筛选应用
KR101983985B1 (ko) 사상체질 진단용 조성물 및 이를 이용한 사상체질 진단방법
KR20190060962A (ko) 소음인 진단용 조성물 및 이를 이용한 소음인 진단방법
KR102612260B1 (ko) 여성의 탈모 진단을 위한 두피 마이크로바이옴 기반바이오 마커, 이를 이용한 탈모를 진단하는 방법, 및 기계 학습을 이용한 마이크로바이옴 기반 바이오 마커를 선별하는 방법
CN107058561A (zh) 自闭症生物标志物及其应用
Traynor The era of genomic epidemiology
Wu et al. Predicting Future Cognitive Decline From Long-Term Observations of Dual-Task Performance Data
KR20240052707A (ko) 구강 미생물총 기반 구강암의 진단
Mahajan et al. Data-driven exploration of cross-body site interactions between oral and gut microbiome
CN117385066B (zh) 一种高血压诊断标志物及其应用
RU2853428C1 (ru) Способ прогнозирования развития психопатологических клинических проявлений
KR20190060961A (ko) 소양인 진단용 조성물 및 이를 이용한 소양인 진단방법
KR20190059882A (ko) 태음인 진단용 조성물 및 이를 이용한 태음인 진단방법
CN120796520A (zh) 一种与肉鸡木质化胸肌相关的粪便菌群标志物、产品及其应用

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230920

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231004

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20231107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240321

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240514

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240710

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20240724

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20240726

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240724

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240903

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241212

R150 Certificate of patent or registration of utility model

Ref document number: 7610810

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150